This persistent imbalance in Treg subsets and impaired Treg function (CD39 and CD73 expression, and associated signaling pathways) may contribute to the impaired suppression of hyperinflammatory reactions, potentially leading to the development of autoimmune diseases and “post-COVID-19” syndrome. The gene discussed is ENTPD1; the disease is autoimmune disease.